NewBridge Pharmaceuticals is a regional specialty company established to bridge the access gap and partner with pharma & biotech companies to in-license and commercialize FDA or EMA/European approved innovative pharmaceutics, biologics, & other healthcare solutions in the Middle East and Africa region.
The areas of Oncology, Immunology, Neuroscience, Gastrointestinal & Rare Disease are NBP’s current strategic focus. The existing product portfolio was built to address unmet medical needs in the region & enabled the company not just to gain substantial presence, but also to help patients gain access to these much-needed innovations.
NewBridge is driven by highly experienced leadership in the biopharmaceutical industry regionally & globally, as well as talented motivated teams with a proven track record of regional achievements, which collectively has allowed NewBridge to establish itself as a strategic & successful pharmaceutical partner of choice in the MENA Region.
NewBridge offers flexible partnership opportunities & best practices in the areas of commercial, regulatory, and medical affairs striving for quality performance & high standards of compliance that pharmaceutical companies look for in a partner to serve as an extension of their practices & values in local markets.
NewBridge is well backed by strong institutional & corporate investors who provide us with the extensive life science network & diverse investment expertise needed to achieve our vision & build a platform of successful alliances in the region, and create value in an innovative business approach.
This integrated strategy of regional expertise & strong global business network position NewBridge uniquely as an institutional one-stop-solution for our partners in its offering & as a preferred partner-of-choice for the biopharmaceutical & other healthcare companies seeking multi-country access in Middle East and Africa with its growing economies, yet complex regulations & access hurdles.
Company Details
- Employees
- 258
- Founded
- -
- Address
- Dubai Science Park, North Tower,17th Floor,united Arab Emirates
- Phone
- 971 44298700
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- nbpharma.com
- Keywords
- In-license and Commercialize FDA or EMA/European approved innovative pharmaceutics, biologics, and other healthcare solutions in the MENA Region, Oncology, Immunology, Neuroscience, Gastrointestinal, Nutrition.
- HQ
- Dubai, Dubai
Newbridge Pharmaceuticals Questions
Newbridge Pharmaceuticals's helpline number is 971 44298700
Newbridge Pharmaceuticals's website is nbpharma.com
Newbridge Pharmaceuticals's LinkedIn profile is https://ae.linkedin.com/company/newbridge-pharmaceuticals
Newbridge Pharmaceuticals has
258 employees.
View email and phone details for 258
employees at Newbridge Pharmaceuticals.
Newbridge Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Newbridge Pharmaceuticals's top competitors are
Vieco Pharmaceuticals,
Globalpharma Llc,
Pharmatrade,
Modern Pharmaceutical Llc,
Tabuk Pharmaceuticals Manufacturing Company,
Adcanpharma,
Pharmax Pharmaceuticals Fz Llc,
Julphar,
Neopharma,
Lifepharma.
Newbridge Pharmaceuticals's support email address is info@nbpharma.com
Newbridge Pharmaceuticals's categories are Pharmaceutical Manufacturing
Newbridge Pharmaceuticals's founding year is 2010
